Acute Metabolic Response Versus Long-term Adaptation to a Vegan Diet
VITAL
1 other identifier
interventional
31
1 country
1
Brief Summary
At baseline, venous blood samples were collected from all eligible participants. The following biochemical parameters were analysed: serum electrolytes (mineral profile), fasting glucose, creatinine, urea nitrogen, total proteins, albumin, bilirubin, liver enzymes, C-reactive protein (CRP), total cholesterol, triacylglycerols (TAG), serum iron, active vitamin D, vitamin B12, complete blood count. At baseline, all participants also underwent standardized anthropometric measurements, including height (cm), body weight (kg) and BMI was calculated accordingly. Body composition was assessed using bioelectrical impedance analysis with the InBody Tanita MC-780MA device. The following parameters were recorded: total body fat (kg, %), visceral fat (kg, %), skeletal muscle mass (kg, %), total muscle mass (kg, %), total body water (kg, %), sarcopenic index (kg/m²), phase angle. To assess health-related quality of life and symptom burden, all participants completed validated questionnaires: World Health Organization Quality of Life - Brief Version (WHOQOL-BREF), Patient Assessment of Gastrointestinal Disorders - Symptom Severity Index (PAGI-SYM), Patient-Reported Outcomes Measurement Information System Global Health-10 (PROMIS-10), Patient Assessment of Upper Gastrointestinal Disorders - Quality of Life (PAGI-QoL) and Patient Health Questionnaire-15 (PHQ-15). After the one-month intervention, participants in the VEG group repeated laboratory testing, anthropometric assessment, body composition analysis, and questionnaire evaluation. The same follow-up assessments were performed in the WD group for comparative purposes. Long-term vegans (VEG-P) did not undergo repeated measurements. Dietary Monitoring and Adherence At study enrolment, all participants were offered a dietary consultation to improve adherence to the assigned dietary regimen. Participants were also instructed to maintain a food diary throughout the study period, which was periodically reviewed via telephone or email consultation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 5, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2024
CompletedFirst Submitted
Initial submission to the registry
July 15, 2026
CompletedFirst Posted
Study publicly available on registry
July 28, 2026
CompletedJuly 28, 2026
July 1, 2026
1.3 years
July 15, 2026
July 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
The difference in body weight (kg), between healthy vegans (more than 2 years) and omnivores.
To comprehensively compare body weight among individuals following different dietary patterns (long-term vegans and omnivores).
Baseline
The difference in body weight (kg) between omnivores and intervention group (omnivores transitioned to vegan diet).
To comprehensively compare body weight among individuals following different dietary patterns (long-term omnivores and intervention group).
From baseline to the end of intervention at 4 weeks
The difference in lipid profile (total cholesterol, triglycerides), between healthy vegans (more than 2 years) and omnivores.
At baseline, venous blood samples were collected from all eligible participants to analyse lipid profile: total cholesterol (mmol/l), triaglycerides (mmol/l).
Baseline
The difference in C-reactive protein (CRP), between healthy vegans (more than 2 years) and omnivores.
At baseline, venous blood samples were collected from all eligible participants to analyse CRP (mg/l).
Baseline
The difference in lipid profile (total cholesterol, triglycerides) between omnivores and intervention group (omnivores transitioned to vegan diet).
To comprehensively compare lipid profile parameters among individuals following different dietary patterns (long-term omnivores and intervention group). Venous blood samples were analyzed to measure total cholesterol (mmol/l) and triglycerides (mmol/l).
From baseline to the end of intervention at 4 weeks
The difference in C-reactive protein (CRP) between omnivores and intervention group (omnivores transitioned to vegan diet).
To comprehensively compare CRP parameters among individuals following different dietary patterns (long-term omnivores and intervention group). Venous blood samples were analyzed to measure CRP (mg/l).
From baseline to the end of intervention at 4 weeks.
Secondary Outcomes (5)
World Health Organization Quality of Life - Brief Version (WHOQOL-BREF)
From baseline to the end of intervention at 4 weeks
Patient Assessment of Gastrointestinal Disorders - Symptom Severity Index (PAGI-SYM).
From baseline to the end of intervention at 4 weeks.
Patient-Reported Outcomes Measurement Information System Global Health-10 (PROMIS-10).
From baseline to the end of intervention at 4 weeks.
Patient Assessment of Upper Gastrointestinal Disorders - Quality of Life (PAGI-QoL).
From baseline to the end of intervention at 4 weeks.
Patient Health Questionnaire-15 (PHQ-15).
From baseline to the end of intervention at 4 weeks.
Study Arms (1)
VEG
EXPERIMENTALomnivores transmitted to vegan diet
Interventions
Eligibility Criteria
You may qualify if:
- Age ≥ 18 years
- Healthy individuals without chronic disease
- BMI between 18 and 30 kg/m²
- Provision of written informed consent
- For the VEG-P group: exclusive adherence to a plant-based diet for at least 2 years
- For the WD group: regular consumption of animal products for at least 2 years
You may not qualify if:
- Active infection
- Eating disorder
- Severe or unstable metabolic disease (e.g., diabetes mellitus)
- Endocrine disorders
- BMI \< 18 or \> 30 kg/m²
- Age \< 18 years
- Current or past malignancy
- Systemic corticosteroid therapy
- Hormone replacement therapy
- Pregnancy
- Inability to complete follow-up assessments
- Excessive alcohol consumption
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Martin
Martin, Žilina Region, 03601, Slovakia
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Investigator
Study Record Dates
First Submitted
July 15, 2026
First Posted
July 28, 2026
Study Start
February 16, 2023
Primary Completion
June 5, 2024
Study Completion
June 5, 2024
Last Updated
July 28, 2026
Record last verified: 2026-07